Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

FOXO4-DRI is a research peptide investigated for its ability to selectively interact with cellular pathways associated with senescence. Preclinical studies suggest that modulation of senescent cell populations may support improvements in biological function and tissue-level homeostasis in experimental models of aging.  According to experimental and preclinical research observations, FOXO4-DRI has been associated with the following effects: Selective induction of apoptosis in senescent cells in laboratory models Improvement of physical performance parameters in aging animal studies Support of tissue and organ function markers in preclinical research Contribution to the restoration of tissue homeostasis under experimental conditions      

GcMAF Frag (Gc protein–derived macrophage activating factor fragment) is a peptide fragment derived from vitamin D–binding protein (DBP) and studied for its interaction with macrophages, key cells of the innate immune system involved in immune surveillance and phagocytic processes. In experimental and preclinical research settings, GcMAF Frag has been investigated for its ability to influence macrophage-associated signaling pathways and immune-related functional markers. Within controlled laboratory models, exposure to GcMAF-related fragments has been associated with modulation of macrophage activity, including phagocytosis-related assays and cytokine-associated readouts. For this reason, the peptide is primarily used as a research tool in studies focused on immune regulation, inflammatory signaling, and host defense mechanisms. Chemical modifications such as N-terminal acetylation and C-terminal amidation have been evaluated in peptide research for their impact on structural stability and resistance to enzymatic degradation. In experimental systems, these features may contribute to enhanced molecular stability, prolonged functional persistence, and optimized receptor interaction profiles under in vitro conditions.

GDF11 has been shown to improve the outcomes of neurodegenerative and neurovascular diseases, increase the amount of skeletal muscle and boost muscular strength. It also has the power to reverse age-related degenerative alterations, as well as govern organ and skin regeneration following damage. These are all examples of its biological effects, which include reversing senescence.

GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration. Experimental and preclinical research indicates that modulation of this pathway influences muscle and tissue dynamics associated with repair and adaptation. According to research-based observations, GDF-8 has been associated with the following effects: Enhancement of muscular regeneration and recovery processes following injury Support of the body’s regenerative capacity at the tissue level Increase in myofiber hypertrophy in experimental models

GHK with DAC is a modified form of the naturally occurring tripeptide GHK that has been engineered to enhance stability and prolong its persistence in experimental systems. Like native GHK, it has been widely investigated in laboratory and preclinical research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes Modulation of fibrinogen-related pathways Activation of DNA repair–related gene networks Engagement of the ubiquitin/proteasome system Influence on insulin and insulin-like signaling pathways. The addition of DAC (Drug Affinity Complex or stabilizing moiety) is designed to enhance resistance to enzymatic degradation and extend the duration of peptide activity in experimental conditions. This modification may allow for more sustained interaction with biological systems, supporting improved observation of time-dependent and cumulative effects in research models. Collectively, these properties make GHK with DAC a molecule of interest in research areas such as tissue regeneration, aging mechanisms, metabolic regulation, and cellular homeostasis, particularly in experimental settings where prolonged peptide exposure is required.

GHK is a naturally occurring tripeptide that has been widely investigated in experimental and laboratory research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes: Linked to collagen-related pathways and cellular mechanisms involved in wound repair and tissue maintenance. Modulation of fibrinogen-related pathways: Associated with inflammatory signaling regulation and vascular biology mechanisms in experimental models. Activation of DNA repair–related gene networks: Observed to influence pathways connected to genomic stability and cellular maintenance. Engagement of the ubiquitin/proteasome system: Studied for its role in supporting protein quality control and cellular homeostasis. Influence on insulin and insulin-like signaling pathways: Associated with metabolic regulation mechanisms in gene expression studies. Collectively, these properties make GHK a molecule of interest in research areas such as cardiovascular biology, aging mechanisms, metabolic regulation, and tissue regeneration. 

GHK-Cu with DAC is a modified version of the well-characterized copper tripeptide Gly-His-Lys (GHK), in which the peptide is conjugated with a stabilizing Maleimide-β-Ala linker designed to influence its persistence and interaction dynamics in experimental settings. Native GHK-Cu has been extensively studied for its involvement in tissue remodeling, extracellular matrix regulation, and cellular signaling processes. The addition of a DAC-type linker is intended to enhance the stability of the peptide and extend its functional presence in biological systems, allowing for more sustained interaction with target pathways under controlled research conditions. This modification does not alter the core peptide sequence but may influence how the compound behaves in terms of degradation resistance, distribution, and temporal activity profile. In laboratory and preclinical research, GHK-Cu has been associated with modulation of gene expression related to skin structure, cellular repair, inflammatory signaling, and oxidative balance. The DAC-conjugated form is therefore investigated as an extended-activity variant, suitable for studies requiring prolonged exposure and more stable peptide dynamics. All observations related to GHK-Cu and its modified forms derive from in vitro systems, animal studies, or other experimental models and are intended exclusively for scientific research purposes.

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content  VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040578GHK-Cu is a naturally occurring copper-binding tripeptide widely studied for its role in tissue maintenance, cellular repair, and gene-regulatory processes. Research has associated GHK-Cu with multiple biological activities relevant to skin biology, cellular regeneration, and protective mechanisms at the molecular level. According to experimental and research observations, GHK-Cu has been associated with the following effects: Improves skin density and firmness Reduces the appearance of fine lines and deeper wrinkles Helps counteract photodamage related to environmental exposure Supports biological processes linked to hair follicle activity Demonstrates gene-regulatory activity relevant to cancer research models Supports mechanisms involved in nerve regeneration Activates pathways associated with DNA repair and cellular recovery All listed effects are derived from laboratory, preclinical, or controlled research contexts and are presented for scientific and educational purposes only.

GHRP-2 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its targeted receptor activity, GHRP-2 remains a compound of interest in experimental models investigating signaling mechanisms related to growth hormone regulatory pathways and systemic endocrine coordination.

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

HGH (191 AA) is a recombinant peptide hormone studied in research contexts for its role in endocrine signaling and systemic physiological regulation. It is associated with complex signaling pathways involved in cellular communication, metabolic coordination, and tissue-level regulatory processes. Due to its broad receptor distribution and multi-system activity, HGH remains a key subject of investigation in experimental models exploring integrative endocrine and metabolic mechanisms.  

HGH Fragment (176–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. It is studied in research contexts for its selective interaction with signaling pathways associated with lipid metabolism and energy regulation. Unlike full-length HGH, this fragment demonstrates a more targeted activity profile, making it a subject of investigation in experimental models focused on metabolic signaling and pathway-specific regulatory mechanisms.

Humanin is a 24–amino acid mitochondrial-derived peptide in which each residue contributes to its biological activity. A key residue is serine at position 14, which is associated with neuroprotective properties. Substitution of this amino acid with glycine results in a more potent variant known as Humanin-G (HNG). Experimental research indicates that HNG exhibits substantially enhanced biological activity compared to native Humanin and is particularly effective in preserving mitochondrial function and cellular integrity under stress conditions. In preclinical and laboratory research settings, Humanin-G has been shown to support cellular survival by limiting mitochondrial dysfunction and reducing pathways associated with programmed cell death. These properties have generated scientific interest in its role within research models of ischemic injury, neurodegenerative processes such as Alzheimer’s disease, and other conditions linked to cellular stress. Based on experimental observations, Humanin-G has been associated with:  Protection against mitochondrial dysfunction in stressed cells Reduction of apoptosis-related cellular pathways Support of cellular longevity mechanisms in research models Modulation of insulin sensitivity in experimental systems Neuroprotective effects observed in models of ischemia and neurodegeneration

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1, designed to exhibit modified binding characteristics and extended activity in research environments. It is studied for its interaction with cellular signaling pathways involved in growth factor regulation, intercellular communication, and system-wide biological coordination. Due to its structural modifications and prolonged activity profile, IGF-1 LR3 remains a key compound in experimental models investigating complex signaling dynamics and regulatory mechanisms at the cellular level.

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue and a ghrelin receptor (GHS-R1a) agonist. It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its selective receptor activity profile, ipamorelin remains a compound of interest in experimental models investigating growth hormone–related signaling and neuroendocrine regulatory mechanisms.

Research and experimental studies indicate that KCF-18 is associated with the following characteristics and biological activities: Interaction with multiple pro-inflammatory cytokine pathways, including TNF-α, IL-1β, and IL-6 Functioning as a cytokine-binding decoy in experimental models Modulation of inflammatory signaling involved in vascular and endothelial processes Influence on immune cell adhesion and transmigration in laboratory settings Potential role in the regulation of immune response signaling Structural design that supports interaction with multiple cytokine-related targets

Kisspeptin is a naturally occurring peptide in humans that has been extensively studied for its role in hormonal signaling associated with puberty and reproductive function. In research settings, it has also been linked to regulatory processes involving renal function, angiogenesis, testosterone modulation, and mood- and behavior-related neural pathways. The peptide has been identified in the brain and has been investigated for its association with mechanisms that limit tumor development and metastatic progression in experimental models. Of particular scientific interest is kisspeptin’s ability to influence gonadotropin-releasing hormone (GnRH) signaling, positioning it as a key regulator within the neuroendocrine system. Additional research suggests that kisspeptin may be involved in biological processes relevant to aging and age-associated functional changes.

KPV is a short peptide that has been extensively investigated in experimental models for its role in the modulation of inflammatory responses. Current research has focused primarily on its involvement in studies related to inflammatory bowel disease. Additional studies in wound-healing models suggest that KPV, along with other α-MSH–derived peptides, may influence tissue repair processes, inflammatory regulation, microbial control, and structural outcomes associated with healing. According to experimental and preclinical research, KPV has been studied in relation to: Inflammatory mechanisms associated with acne and cystic acne Intestinal inflammatory signaling in Crohn’s disease research models Experimental models of ulcerative colitis and irritable bowel syndrome Inflammatory skin conditions such as eczema and psoriasis Immune and inflammatory responses explored in mold- and Lyme-related models Neuroinflammatory pathways investigated in multiple sclerosis research Inflammatory conditions affecting skin and ocular tissues Airway inflammation examined in allergic asthma models Joint inflammation studied in arthritis-related research

L-Glutathione is a naturally occurring tripeptide that has been extensively studied for its central role in cellular protection and metabolic balance. Research and experimental data indicate that L-Glutathione is associated with the following biological processes: Regulation of intracellular redox balance and antioxidant defenses Protection of cells from oxidative stress and reactive oxygen species Support of detoxification and cellular clearance pathways Modulation of immune and inflammatory signaling mechanisms Maintenance of mitochondrial function and cellular energy metabolism Preservation of protein structure and prevention of oxidative damage Involvement in cellular stress adaptation and aging-related processes

L-Glutathione is a naturally occurring tripeptide that has been extensively studied for its central role in cellular protection and metabolic balance. Research and experimental data indicate that L-Glutathione is associated with the following biological processes: Regulation of intracellular redox balance and antioxidant defenses Protection of cells from oxidative stress and reactive oxygen species Support of detoxification and cellular clearance pathways Modulation of immune and inflammatory signaling mechanisms Maintenance of mitochondrial function and cellular energy metabolism Preservation of protein structure and prevention of oxidative damage Involvement in cellular stress adaptation and aging-related processes

Livagen is a short bioregulatory peptide that has been investigated in experimental research for its influence on DNA organization and gene expression. It is primarily recognized for its association with chromatin decondensation, a process that increases DNA accessibility and has been linked to cellular profiles typically observed in younger cells. Scientific research has focused predominantly on immune system lymphocytes, where Livagen has been shown to modulate gene activity and cellular function. Through these mechanisms, Livagen has been studied for its involvement in biological processes related to immune regulation and signaling pathways associated with cardiovascular, gastrointestinal, neurological, and immune system function. Experimental findings have also explored Livagen’s role in nociception and pain-related signaling. Ongoing research continues to examine Livagen’s broader relevance in studies of aging, cellular senescence, and long-term biological regulation.

LL-37 is the only known human member of the cathelicidin family, a broad class of proteins commonly referred to as antimicrobial peptides (AMPs). These peptides are primarily expressed in macrophages and polymorphonuclear leukocytes, where they contribute to innate immune defense against microbial threats. Beyond their antimicrobial role, experimental research has demonstrated that LL-37 is involved in a wide range of biological processes related to immune regulation, inflammation, tissue repair, and cellular signaling. For this reason, LL-37 has been extensively studied in research models relevant to cancer biology, autoimmune mechanisms, inflammatory conditions, and wound-related processes. According to experimental research, LL-37 has been investigated in relation to: Inflammatory processes associated with rheumatoid arthritis Immune dysregulation studied in lupus models Chronic and acute inflammatory conditions Vascular inflammation relevant to atherosclerosis research Skin inflammation examined in psoriasis models Intestinal inflammation studied in colitis research Gastrointestinal inflammatory signaling in Crohn’s disease models Tissue injury and repair processes associated with ulcers Impaired wound-healing environments such as diabetic foot models Cellular and immune mechanisms explored in cancer research Broad antimicrobial activity within innate immune defense systems